Skip to main content

Table 1 Studies included in this review by study design, study population characteristics and sample size

From: Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review

Authors Year of publication Country of the study Methods Study design Timing Study Population Sample size Sex ratio (M/F) Age range (years) Patients with CL scars included
Al-Kamel et al. 2017 Yemen Qualitative Interview May 2016 CL patients 11 0.10 12–60 Yes
Bennis et al. 2017 Morocco Qualitative Questionnaire April 2015 Boarding school students 448 1.36 16–20 Yes
Chahed et al. 2016 Tunisia Quantitative Questionnaire survey (scale) Not defined Women with CL scar 41 All female 12–53 Yes
Ramdas et al. 2016 Surinam Qualitative Ethnography Sep 09 to Dec 10 CL patients. General population 205CL patient & 321 people 8.3 & 1.4 20–49 Yes
Turan et al. 2015 Turkey Quantitative Questionnaire survey (scale) May 11 to Apr 13 Paediatric CL patients and healthy controls 54 CL patients 1.16 7–18 No
Handjani et al. 2013 Iran Quantitative Questionnaire survey (scale) 2013 Relatives of dermatological cases 50 relatives 0.85 20–65 No
Vares et al. 2013 Iran Quantitative Questionnaire survey (scale) Not defined CL patients 124 0.59 16–80 Yes
Abazid et al. 2010 Syria Quantitative KAP-survey Nov 06 to Oct 07 CL patients or the caregiver seeking treat 70 0.46 ≈32 No
Fernando et al. 2010 Sri Lanka Quantitative KAP-survey Sep 06 to Feb 08 CL patients 120 2.75 02–70 No
Nilforoushzadeh et al. 2010 Iran Quantitative RCT 2007 Female CL patients 2 groups of 20 All female >  10 No
Kassi et al. 2008 Afghanistan Qualitative Case report Not defined Woman with CL scar 1 All female 28 Yes
Simsek et al. 2008 Turkey Quantitative Questionnaire survey (scale) 2006 Women in general population 247 All female 15–47 Yes
Reithinger et al. 2005 Afghanistan Mixed KAP & FGD Oct 2002 KAP: household head; FGD: women KAP: 252; FGD: 108 FGD All female Not defined Yes
Yanik et al. 2004 Turkey Quantitative Questionnaire survey (scale) Sep 02 to Aug 03 CL patients, persons with CL scar, healthy controls 3 groups of 33 1:1 12–35 Yes
Reyburn et al. 2000 Afghanistan Qualitative FGD Feb to Jul 1998 CL patients and unaffected spouses 8 groups of 6 to 10 1:1 ≈28 Yes